Allene M. Diaz

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Ionis Pharmaceuticals Inc., 3 years.

3 years · Since 2023

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 7, 2026 Ionis Pharmaceuticals Inc. Option exercise +10,111 $47.11 $476,329
Jul 7, 2026 Ionis Pharmaceuticals Inc. Open-market sale −10,111 $85.42 $863,682
Mar 3, 2026 Ionis Pharmaceuticals Inc. Option exercise +10,321 $41.08 $423,987
Mar 3, 2026 Ionis Pharmaceuticals Inc. Option exercise +12,000 $38.06 $456,720
Mar 3, 2026 Ionis Pharmaceuticals Inc. Option exercise +18,000 $40.05 $720,900
Mar 3, 2026 Ionis Pharmaceuticals Inc. Open-market sale −39,265 $79.11 $3,106,254
Mar 3, 2026 Ionis Pharmaceuticals Inc. Open-market sale −14,608 $79.88 $1,166,887
Mar 3, 2026 Ionis Pharmaceuticals Inc. Open-market sale −1,005 $80.80 $81,204
Aug 22, 2025 Ionis Pharmaceuticals Inc. Open-market sale −1,427 $42.53 $60,690
Jul 15, 2025 Ionis Pharmaceuticals Inc. Option exercise +4,079 — —
Jul 16, 2024 Ionis Pharmaceuticals Inc. Open-market sale −900 $48.94 $44,046
Jul 16, 2024 Ionis Pharmaceuticals Inc. Open-market sale −737 $50.17 $36,975
Jul 15, 2024 Ionis Pharmaceuticals Inc. Option exercise +4,677 — —
Aug 1, 2023 Ionis Pharmaceuticals Inc. Open-market sale −657 $41.05 $26,970
Jul 17, 2023 Ionis Pharmaceuticals Inc. Option exercise +5,333 — —

Questions about Allene M. Diaz

What boards is Allene M. Diaz on?

Allene M. Diaz sits on the board of Ionis Pharmaceuticals Inc.

How long has Allene M. Diaz served on boards?

Our records show at least 3 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.